Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Effects of Treatment for Depression on Fatigue in Multiple Sclerosis

Mohr, David C., Hart, Stacey L., Goldberg, Alison·2003·Psychosomatic Medicine

Abstract

OBJECTIVE: There has long been a belief that depression contributes to fatigue in multiple sclerosis (MS) although supporting data are minimal at best. Clinical guidelines for the treatment of fatigue include recommendations for the treatment of depression in the absence of clear empirical support. The goal of this study was to examine the effects of treatment for depression on fatigue in MS. METHODS: Sixty patients with a relapsing form of MS and moderate to severe depression were randomly assigned to one of three validated 16-week treatments for depression: individual cognitive behavioral therapy, group psychotherapy, or sertraline. Assessments at baseline and treatment cessation included the primary outcome measure, fatigue assessment instrument (FAI), and Beck depression inventory (BDI). RESULTS: The total FAI and the global fatigue severity subscale were significantly reduced over the course of treatment (p values <.02). Other subscales did not change significantly. Secondary analyses showed change in global fatigue severity was associated with change in BDI (p =.03) but change in total FAI was only marginally related to change in BDI (p =.05). These relationships were due entirely to change in mood (p values <.02) and not to change in cognitive or vegetative symptoms (p values >.17). CONCLUSIONS: These findings suggest that treatment for depression is associated with reductions in the severity of fatigue symptoms, and that this relationship is due primarily to treatment related changes in mood.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.psy.0000074757.11682.96

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 37

  1. Anderson, 1992, Revised estimate of the prevalence of multiple sclerosis in the United States., Ann Neurol, 31, 333, 10.1002/ana.410310317 · DOI · Paper page
  2. Freal, 1984, Symptomatic fatigue in multiple sclerosis., Arch Phys Med Rehabil, 65, 135
  3. Krupp, 1988, Fatigue in multiple sclerosis., Arch Neurol, 45, 435, 10.1001/archneur.1988.00520280085020 · DOI · Paper page
  4. Aronson, 1997, Quality of life among persons with multiple sclerosis and their caregivers., Neurology, 48, 74, 10.1212/WNL.48.1.74 · DOI · Paper page
  5. Ford, 1998, The nature of fatigue in multiple sclerosis., J Psychosom Res, 45, 33, 10.1016/S0022-3999(98)00004-X · DOI · Paper page
  6. Schwartz, 1996, Psychosocial correlates of fatigue in multiple sclerosis., Arch Phys Med Rehabil, 77, 165, 10.1016/S0003-9993(96)90162-8 · DOI · Paper page
  7. Bakshi, 1999, Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients., Neurology, 53, 1151, 10.1212/WNL.53.5.1151 · DOI · Paper page
  8. Mainero, 1999, Fatigue and magnetic resonance imaging activity in multiple sclerosis., J Neurol, 246, 454, 10.1007/s004150050382 · DOI
  9. Roelcke, 1997, Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study., Neurology, 48, 1566, 10.1212/WNL.48.6.1566 · DOI · Paper page
  10. Van der Werf, 1998, Fatigue in multiple sclerosis: Interrelations between fatigue complaints, cerebral MRI abnormalitites, and neurological disability., J Neurol Sci, 160, 164, 10.1016/S0022-510X(98)00251-2 · DOI · Paper page
  11. Bergamaschi, 1997, Clinical aspects of fatigue in multiple sclerosis., Funct Neurol, 12, 247
  12. Colosimo, 1995, Fatigue in MS is associated with specific clinical features., Acta Neurol Scand, 92, 353, 10.1111/j.1600-0404.1995.tb00145.x · DOI
  13. Sadovnick, 1996, Depression and multiple sclerosis., Neurology, 46, 628, 10.1212/WNL.46.3.628 · DOI · Paper page
  14. Schubert, 1993, Increased depression in multiple sclerosis: A meta-analysis., Psychosomatics, 34, 124, 10.1016/S0033-3182(93)71902-7 · DOI
  15. Vercoulen, 1996, The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects., Arch Neurol, 53, 642, 10.1001/archneur.1996.00550070080014 · DOI · Paper page
  16. Krupp, 1995, Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo., Neurology, 45, 1956, 10.1212/WNL.45.11.1956 · DOI · Paper page
  17. Weinshenker, 1992, A doubleblind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis., Neurology, 42, 1468, 10.1212/WNL.42.8.1468 · DOI
  18. Mohr, 1997, Identification of Beck Depression Inventory items related to multiple sclerosis., J Behav Med, 20, 407, 10.1023/A:1025573315492 · DOI
  19. Leventhal, 1996, Negative affect and self-report of physical symptoms: two longitudinal studies of older adults., Health Psychol, 15, 193, 10.1037/0278-6133.15.3.193 · DOI
  20. Watson, 1988, Intraindividual and interindividual analyses of positive and negative affect: Their relation to health complaints, perceived stress, and daily activities., J Pers Soc Psychol, 54, 1020, 10.1037/0022-3514.54.6.1020 · DOI · Paper page
  21. Louks, 1989, Replicated factor structure of the Beck Depression Inventory., J Nerv Ment Dis, 177, 473, 10.1097/00005053-198908000-00004 · DOI
  22. Startup, 1992, Components of major depression examined via the Beck Depression Inventory., J Affect Disord, 26, 251, 10.1016/0165-0327(92)90103-D · DOI
  23. Poser, 1983, New diagnostic criteria for multiple sclerosis: guidelines for research protocols., Ann Neurol, 13, 227, 10.1002/ana.410130302 · DOI · Paper page
  24. Lublin, 1996, Defining, the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis., Neurology, 46, 907, 10.1212/WNL.46.4.907 · DOI · Paper page
  25. Beck, 1961, An inventory for measuring depression., Arch Gen Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
  26. Scott, 1996, Characterization of major depression symptoms in multiple sclerosis patients., J Neuropsychiatry Clin Neurosci, 8, 318, 10.1176/jnp.8.3.318 · DOI
  27. Schwartz, 1993, The measurement of fatigue: a new instrument., J Psychosom Res, 37, 753, 10.1016/0022-3999(93)90104-N · DOI · Paper page
  28. Rao, 1991, Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction., Neurology, 41, 685, 10.1212/WNL.41.5.685 · DOI · Paper page
  29. Mack, 1992, Boston Naming Test. shortened versions for use in Alzheimers disease., J Gerontol, 47, 154, 10.1093/geronj/47.3.P154 · DOI · Paper page
  30. Beatty, 1996, Problem solving by patients with multiple sclerosis: comparison of performance on the Wisconsin and California Card Sorting Tests., J Int Neuropsychol Soc, 2, 134, 10.1017/S1355617700000989 · DOI
  31. Hauser, 1983, Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH., N Engl J Med, 308, 173, 10.1056/NEJM198301273080401 · DOI · Paper page
  32. Schwartz, 1999, Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research., Soc Sci Med, 48, 1531, 10.1016/S0277-9536(99)00047-7 · DOI · Paper page
  33. Noseworthy, 2000, Multiple sclerosis., N Engl J Med, 343, 938, 10.1056/NEJM200009283431307 · DOI · Paper page
  34. Hohlfeld, 1995, The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis., Neurology, 45, S33, 10.1212/WNL.45.6_Suppl_6.S33 · DOI
  35. Dalos, 1983, Disease activity and emotional state in multiple sclerosis., Ann Neurol, 13, 573, 10.1002/ana.410130517 · DOI
  36. Fassbender, 1998, Mood disorders and dysfunction of the hypothalamicpituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation., Arch Neurol, 55, 66, 10.1001/archneur.55.1.66 · DOI · Paper page
  37. Mohr, 2001, Treatment of depression is associated with suppression of nonspecific and antigenspecific T(H)1 responses in multiple sclerosis., Arch Neurol, 58, 1081, 10.1001/archneur.58.7.1081 · DOI

Cited by

See all 184

Metadata

Authors
Mohr, D. C., Hart, S. L., & Goldberg, A.
Venue
Psychosomatic Medicine
Published
2003-07
Volume
65
Issue
4
Pages
542-547
ISSN
0033-3174 (ISSN-L)
OpenAlex
W2028898514
Cited by
184
References
6
FWCI
5.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Treatment for Depression on Fatigue in Multiple Sclerosis. https://app.cochat.ai/papers/10.1097/01.psy.0000074757.11682.96
The paper
Mohr, D. C., Hart, S. L., & Goldberg, A. (2003). Effects of Treatment for Depression on Fatigue in Multiple Sclerosis. Psychosomatic Medicine. https://doi.org/10.1097/01.psy.0000074757.11682.96

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.